Checks before care, help after it

The person making the decision

The public record of a doctor’s license and board discipline is held by the state medical board.

Some states have more than one licensing board for doctors.

An absence of public discipline is not a quality score for the care someone provides.

HHS (the Department of Health and Human Services) says a doctor or other health professional needs a license or other legal permission in the state where you receive the online care, as of November 3, 2026. The professional must also meet the licensing rules where they are located.

State rules supply the binding requirements and can include exceptions.

• Ask for the full name and type of license, then use the relevant board’s public record.
• Tell the service your location for the call; mention any travel that would change it.
• Ask which board covers the person’s professional role.

A doctor lookup is not a lookup for every health profession.

The pharmacy behind the parcel

The pharmacy board keeps a pharmacy’s license record. It is a different body from the medical board.

For pharmacy licenses, follow the search links published by the Food and Drug Administration (FDA).

A listed license does not, by itself, prove that every dispensing decision is appropriate.

Most states expect another state’s pharmacy to obtain a local permit or license before shipping to their residents, as of November 3, 2026.

• Ask which pharmacy prepares, dispenses and ships the proposed medicine.
• Match the supplied name to the state board record.
• Ask how a pharmacist can be reached for questions.

FDA’s pharmacy checklist calls for a licensed pharmacist available to answer questions.

It also cautions that a convincing website can hide an unsafe pharmacy.

Claims that need a pause

As of November 3, 2026, “FDA registered” means the facility has an entry in FDA’s records. An entry like this approves neither the facility itself nor the drugs made there.

For a registered compounding facility, FDA checks that the registration information is complete before putting it on the list. Listed facilities can be waiting for their first FDA inspection. The listing alone cannot tell you that the medicine has been checked.

A compounded medicine is also not FDA-approved, as of November 3, 2026.

Ask what the approval claim refers to: the proposed finished product, an ingredient or a business’s registration. Write down the exact claim. If the answer changes subject, return to the product under discussion.

Semaglutide has FDA-approved products for type 2 diabetes and weight management, including Ozempic (semaglutide) and Wegovy (semaglutide), as of November 3, 2026. Each product has its own approved uses; the warning below concerns compounded shots.

As of November 3, 2026, FDA has received reports of people getting the wrong amount of compounded semaglutide in a shot. Those mistakes may have caused harm; some reports involved hospital treatment.

Keep any question about an amount, unclear directions or a changed label for the prescriber and pharmacist.

• Ask for unclear instructions to be resolved by the people responsible for the prescription.
• Ask who answers if the supplied product differs from what was discussed.

Urgent help and reporting

MedlinePlus uses “anaphylaxis” for an allergic reaction severe enough to be life-threatening.

MedlinePlus lists a swollen tongue and difficulty breathing among severe allergic-reaction symptoms. Its urgent-help direction is to dial 911 or the local emergency number.

An online question list is not an emergency assessment. Keep urgent care separate from a routine request for a reply.

MedWatch is FDA’s program through which people can report a problem involving a medical product.

Sending a report flags a concern; it does not prove that the drug caused the event.

Keep the name of the product and your own account of what happened available for the conversation about the problem. The source page links to reporting and urgent-help information.